![Torsten Rieck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Torsten Rieck
Corporate Officer/Principal en Boehringer Ingelheim International GmbH .
Origen de la red de primer grado Torsten Rieck.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Boehringer Ingelheim International GmbH
![]() Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.
4
| Subsidiary | Biotechnology | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Torsten Rieck a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Boehringer Ingelheim RCV GmbH & Co. KG
![]() Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member Director/Board Member | |
Boehringer Ingelheim Corporate Center GmbH
![]() Boehringer Ingelheim Corporate Center GmbH Real Estate DevelopmentFinance Founded in 2016, Boehringer Ingelheim Corporate Center GmbH is a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The company is based in Ingelheim am Rhein, Germany and specializes in leasing real estate properties. | Real Estate Development | Chief Executive Officer Chief Executive Officer | |
Boehringer Ingelheim GmbH
![]() Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
KWS SAAT SE & CO. KGAA | Miscellaneous Commercial Services | Director/Board Member | |
Boehringer Ingelheim AB
![]() Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Profunda Verwaltungs GmbH
![]() Profunda Verwaltungs GmbH Investment ManagersFinance Part of Profunda Verwaltungs GmbH & Co. KG, the German company provides asset management services. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Hubertus von Baumbach, Christoph Gauger. | Investment Managers | Chief Executive Officer | |
Cobepa SA
![]() Cobepa SA Financial ConglomeratesFinance Cobepa SA is an investment holding Belgian company. The company is based in Brussels, Belgium. The company was founded in 1957. The CEO is Jean-Marie Laurent Josi. | Financial Conglomerates | Director/Board Member | |
Boehringer Ingelheim Pharma GmbH & Co., KG
![]() Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Biotechnology | Chief Executive Officer | |
Boehringer Ingelheim (Venture Capital)
![]() Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | President | |
Eyevensys SAS
![]() Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Okairos AG
![]() Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Middle East & Africa GmbH
![]() Boehringer Ingelheim Middle East & Africa GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Middle East & Africa GmbH manufactures pharmaceutical products. The company is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Boehringer Ingelheim Deutschland GmbH
![]() Boehringer Ingelheim Deutschland GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Deutschland GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Beck and Sabine Nikolaus. | Financial Conglomerates | Director/Board Member |
Estadísticas
Internacional
Alemania | 10 |
Austria | 2 |
Suecia | 2 |
Estados Unidos | 2 |
Bélgica | 2 |
Sectorial
Health Technology | 9 |
Finance | 6 |
Commercial Services | 3 |
Operativa
Chief Executive Officer | 9 |
Director/Board Member | 8 |
Corporate Officer/Principal | 5 |
Director of Finance/CFO | 1 |
President | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Hubertus von Baumbach | 11 |
Michel Pairet | 7 |
Torsten Mau | 3 |
Sebastian Guntrum | 0 |
- Bolsa de valores
- Insiders
- Torsten Rieck
- Conexiones Empresas